|

18F-fluciclovine injection Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Newly Diagnosed Multiple Myeloma (NDMM)1
  • Relapsed and/or Refractory Multiple Myeloma (RRMM)1
  • Multiple Myeloma1
  • Cancer1

Bethesda, Maryland1 trial

18F-Fluciclovine PET/CT in Multiple Myeloma

National Institutes of Health Clinical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.